Administrative Core to Lead Phage Therapy Center
Official title: Admin Core
Funded at J. David Gladstone Institutes · NIH-11265553 · Data updated 2026-11-12
The Administrative Core coordinates leadership, compliance, and data sharing for a center focused on phage therapy to fight antibiotic-resistant infections.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | J. David Gladstone Institutes NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | May 11, 2026 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $380,038 |
| NIH project number | 1P01AI195327-01 |
| Project ID | NIH-11265553 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients with antibiotic-resistant infections who may benefit from phage therapy research or who could participate in future related studies.
✕Less likely to help
Patients not involved in phage therapy research or not aligned with the center's ongoing projects may see limited direct benefit.
What this research studies
If you or a loved one faced antibiotic-resistant infections, this program supports a collaborative center that organizes researchers, funds new ideas, and ensures smooth operations. It will handle finances, compliance, data sharing, and event planning while promoting rapid communication among teams. Through standardized data practices and frequent meetings, it aims to accelerate translation of phage therapies from ideas to clinical progress.
Why it matters
Potential benefit: Stronger, faster development and collaboration could speed up future phage-based treatments for infections.
How similar studies have gone: Other centers implementing administrative cores have improved coordination and data sharing, enabling faster progress in targeted therapies.
Where this research is happening
-
J. David Gladstone Institutes
San Francisco, United States Active
Researchers
- Principal investigator: Shipman, Seth L — J. David Gladstone Institutes
- Study coordinator: Shipman, Seth L
Related research
Other NIH-funded projects on the same topics.
-
HOPE: a new approach to silencing HIV and preventing rebound
A large NIH grant is testing a combination strategy to turn off HIV genes in people on treatment so the virus stays gone and health improves.
-
Undo HIV: Understanding and targeting the active HIV reservoir
Aims to map and ultimately eliminate the HIV cells that stay active despite therapy to improve long-term control of HIV in people living with HIV.
-
TREM2 and TYROBP in Alzheimer's brain network changes
This grant looks at how microglial proteins TREM2 and TYROBP influence brain network excitability in people with Alzheimer's disease and related dementias.
-
Commensal respiratory viruses and how they interact with the human airway
A small NIH grant is exploring how the normal viruses living in our airways interact with our cells to stay harmless and support healthy breathing.
-
Targeted delivery systems to edit blood stem cells
Aims to safely deliver genome-editing tools to blood stem cells to treat diseases like acute myeloid leukemia.
-
Regionally Specific Transplants to Restore Breathing After Cervical Spine Injury
A patient-focused look at a study that aims to repair breathing circuits after cervical spinal cord injury using stem-cell–derived nerve cells and targeted neuromodulation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.